Browsing Tag
heart condition
2 posts
28% lower risk of death, 33% risk reduction—Could this be the new standard of care for a deadly heart condition? 🤔
Alnylam Pharmaceuticals recently presented comprehensive results from a clinical trial for its drug, vutrisiran, aimed at treating transthyretin…
August 30, 2024
Cytokinetics Soars to Multi-Decade Highs with Promising Data from Aficamten Trial
Cytokinetics (CYTK), a leading late-stage biopharmaceutical company specializing in treatments for cardiovascular diseases, is currently experiencing a remarkable…
December 28, 2023